Pfizer, Valneva blame low Lyme cases for phase 3 vaccine fail but still plan approval push
Pfizer, Valneva blame low Lyme cases for phase 3 vaccine fail but still plan approval push
Body unavailable. Use the original source.
Pfizer, Valneva blame low Lyme cases for phase 3 vaccine fail but still plan approval push
A compact weekly email covering company moves, product signals, regulatory updates, and notable funding.